How I manage mantle cell lymphoma: indolent versus aggressive disease.
Wilson MR, Barrett A, Cheah CY, Eyre TA.
Br J Haematol. 2023 Apr;201(2):185-198. doi: 10.1111/bjh.18697. Epub 2023 Feb 20.
Non-Hodgkin lymphoma.
Armitage JO, Gascoyne RD, Lunning MA, Cavalli F.
Lancet. 2017 Jul 15;390(10091):298-310. doi: 10.1016/S0140-6736(16)32407-2. Epub 2017 Jan 31.
PET/CT in Non-Hodgkin Lymphoma: An Update.
Zanoni L, Bezzi D, Nanni C, Paccagnella A, Farina A, Broccoli A, Casadei B, Zinzani PL, Fanti S.
Semin Nucl Med. 2023 May;53(3):320-351. doi: 10.1053/j.semnuclmed.2022.11.001. Epub 2022 Dec 14.
Lymphoma.
Mugnaini EN, Ghosh N.
Prim Care. 2016 Dec;43(4):661-675. doi: 10.1016/j.pop.2016.07.012.
MALT lymphoma: epidemiology, clinical diagnosis and treatment.
Violeta Filip P, Cuciureanu D, Sorina Diaconu L, Maria Vladareanu A, Silvia Pop C.
J Med Life. 2018 Jul-Sep;11(3):187-193. doi: 10.25122/jml-2018-0035.
Follicular lymphoma: The long and winding road leading to your cure?
Gordon MJ, Smith MR, Nastoupil LJ.
Blood Rev. 2023 Jan;57:100992. doi: 10.1016/j.blre.2022.100992. Epub 2022 Jul 23.
Follicular lymphoma and marginal zone lymphoma: how many diseases?
Laurent C, Cook JR, Yoshino T, Quintanilla-Martinez L, Jaffe ES.
Virchows Arch. 2023 Jan;482(1):149-162. doi: 10.1007/s00428-022-03432-2. Epub 2022 Nov 17.
Lymphoma Classification.
de Leval L, Jaffe ES.
Cancer J. 2020 May/Jun;26(3):176-185. doi: 10.1097/PPO.0000000000000451.
Lymphoma classification update: T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms.
Jiang M, Bennani NN, Feldman AL.
Expert Rev Hematol. 2017 Mar;10(3):239-249. doi: 10.1080/17474086.2017.1281122. Epub 2017 Jan 29.
Bispecific antibodies in indolent B-cell lymphomas.
Radhakrishnan VS, Davies AJ.
Front Immunol. 2024 Jan 11;14:1295599. doi: 10.3389/fimmu.2023.1295599. eCollection 2023.
